Search research articles
Contact Us
Filters
Showing results (91-100 of 144) with videos related to
Page
of 15
Sort By:
JAMA Oncology
|
January 30, 2016
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study
Marian H Harris, Steven G DuBois, Julia L Glade Bender, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 7, 2018
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Lillian M Guenther, Neekesh V Dharia, Linda Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
British Journal of Cancer
|
March 19, 2019
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group
David S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
British Journal of Cancer
|
August 23, 2018
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group
David S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
Pediatric Blood & Cancer
|
June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force
Sarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Cancer Research
|
March 31, 2011
Differentiation of NUT midline carcinoma by epigenomic reprogramming
Brian E Schwartz, Matthias D Hofer, Madeleine E Lemieux, et al.
JCO Precision Oncology
|
September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
Margaret E Macy, Rajen Mody, Joel M Reid, et al.
Cancer
|
July 30, 2019
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group
Ryan D Roberts, Michael M Lizardo, Damon R Reed, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 144) with videos related to
Sort By:
Page
of 15
JAMA Oncology
|
January 30, 2016
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study
Marian H Harris, Steven G DuBois, Julia L Glade Bender, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 7, 2018
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Lillian M Guenther, Neekesh V Dharia, Linda Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
British Journal of Cancer
|
March 19, 2019
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group
David S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
British Journal of Cancer
|
August 23, 2018
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group
David S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
Pediatric Blood & Cancer
|
June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force
Sarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Cancer Research
|
March 31, 2011
Differentiation of NUT midline carcinoma by epigenomic reprogramming
Brian E Schwartz, Matthias D Hofer, Madeleine E Lemieux, et al.
JCO Precision Oncology
|
September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
Margaret E Macy, Rajen Mody, Joel M Reid, et al.
Cancer
|
July 30, 2019
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group
Ryan D Roberts, Michael M Lizardo, Damon R Reed, et al.
Page
of 15